Men are more likely to die from prostate cancer than women. The biggest risk factors for the disease are old age, inheritance, and lifestyle factors such as smoking and a diet high in red meat. Digital rectal exam (DRE), prostate biopsy, prostate specific antigen (PSA) blood test, bone scan, ultrasound, CT scan, MRI, lymph node biopsy, and ProstaScint monoclonal antibody scan are used to identify cancer.
The growing prevalence of prostate cancer due to an older population, more public awareness, increased demand for Minimally Invasive Prostate Cancer Surgery, and developments in diagnosis techniques are likely to fuel the expansion of the prostate cancer minimally invasive surgery market. Prostate cancer is the fourth most prevalent cancer in both sexes combined, and the second most common cancer in males, according to the World Health Organization (WHO). Prostate cancer was diagnosed in an estimated 1.1 million men worldwide in 2012, accounting for 15% of all malignancies diagnosed in males. Prostate cancer is the sixth greatest cause of mortality in males, accounting for an estimated 307,000 fatalities in 2012.
Read More@ https://bit.ly/3n5tA7W
